At Manningham Medical Centre, you can find all the data about Taxotere More Medical_Authorities. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Taxotere | European Medicines Agency

    https://www.ema.europa.eu/en/medicines/human/EPAR/taxotere
    The most common side effects with Taxotere (seen in more than 1 patient in 10) are neutropenia (low levels of neutrophils, white blood cells that fight infection), …

Taxotere: Uses, Dosage, Side Effects - Drugs.com

    https://www.drugs.com/taxotere.html
    Taxotere can be harmful if it gets on your skin during an IV infusion. If this happens, wash right away with soap and water. Tell your caregivers if you feel any …

Taxotere Lawsuit Update February 2023 – Forbes Advisor

    https://www.forbes.com/advisor/legal/product-liability/taxotere-lawsuit-update/
    In 2022 a separate MDL was established to hear cases involving eye damage stemming from Taxotere use. Both MDLs are being heard in a Louisiana federal …

Taxotere: Package Insert / Prescribing …

    https://www.drugs.com/pro/taxotere.html
    Docetaxel is a white to almost-white powder with an empirical formula of C 43 H 53 NO 14 ∙3H 2 O, …

Taxotere - Chemotherapy Drugs - Chemocare

    https://chemocare.com/chemotherapy/drug-info/Taxotere.aspx
    What Taxotere Is Used For: Approved in treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate …

Taxotere | Understanding the …

    https://www.drugwatch.com/taxotere/
    Taxotere. Docetaxel, sold under the brand name Taxotere, treats cancers of the breast, lung, prostate, stomach, head and neck. It is one of the most popular drugs doctors use …

Taxotere Lawsuit Update February 2023 - Select Justice

    https://www.selectjustice.com/taxotere-lawsuit
    March 1, 2022 - Sanofi wins Taxotere trial over hair loss claims Sanofi is being sued by more than 12,000 people alleging that Taxotere, a breast cancer drug, led to …

Taxotere approved for first-line therapy in NSCLC - | BioWorld

    https://www.bioworld.com/articles/566006-taxotere-approved-for-first-line-therapy-in-nsclc
    Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, …

Safer Alternatives to Taxotere - The Michael …

    https://mblynchfirm.com/pharmaceutical-litigation/taxotere/safer-alternatives-taxotere
    Manufactured by Sanofi-Aventis, Taxotere (docetaxel) is a chemotherapy drug. The FDA approved the drug in 1996 to treat a variety of cancers; however, patients use Taxotere …

High Febrile Neutropenia Risk With Docetaxel in …

    https://www.medscape.com/viewarticle/984921
    Key Results. The incidence of febrile neutropenia was 25% (34/137). Among patients who developed febrile neutropenia, 94% required hospitalization for a mean of …



Need more information about Taxotere More Medical_Authorities?

At Manningham Medical Centre, we collected data on more than just Taxotere More Medical_Authorities. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.